Keiichi Aritomo

2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 32 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +13

6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors

Fumiaki Uehara, Aya Shoda, Keiichi Aritomo et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 28 citations · Full text

Molecular Pharmacology, Medicine, Drug Development +4

Structural Characterization of Cyclic ADP-Ribose by NMR Spectroscopy

Takeshi Wada, Kiyoshi Inageda, Keiichi Aritomo et al. · Nucleosides and Nucleotides · 1995 · 21 citations

Nmr Spectroscopy, Biochemistry, Cyclic Adp-ribose +12

Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists

Masahiro Eda, Tomoko Kuroda, Satoshi Kaneko et al. · Journal of Medicinal Chemistry · 2015 · 19 citations · Full text

Psychopharmacology, Pharmacotherapy, Glucocorticoid +20

Alkylation of 6-N-acylated adenosine derivatives by the use of phase transfer catalysis

Keiichi Aritomo, Takeshi Wada, Mitsuo Sekine · Journal of the Chemical Society Perkin Transactions 1 · 1995 · 18 citations

Bioorganic Chemistry, Engineering, Organic Chemistry +18